Genomic Valley Biotech Shareholding

Genomic Valley Biotech Ltd Shareholding Pattern

The Genomic Valley Biotech Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Genomic Valley Biotech Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Genomic Valley Biotech Ltd (NSE: , BSE: 539206) operates in the Health technology sector and Biotechnology industry. Monitoring the Genomic Valley Biotech Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Genomic Valley Biotech Ltd Shareholding Pattern (Latest)

The latest Genomic Valley Biotech Ltd shareholding for Mar 2026 is:

• Promoters: 46.06%
• FII: 0%
• DII: 0%
• Public: 53.94%
• Government: 0%

Promoter holding in Genomic Valley Biotech Ltd remains stable, reflecting consistent long-term commitment.

Genomic Valley Biotech Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Genomic Valley Biotech Ltd.

• Mar 2026: 46.06%
• Dec 2025: 46.06%
• Sept 2025: 46.72%
• Jun 2025: 46.72%
• Mar 2025: 46.78%

Promoter stake remains largely stable, showing consistent ownership structure.

Genomic Valley Biotech Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Genomic Valley Biotech Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Genomic Valley Biotech Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

DII holdings remain stable, reflecting steady institutional participation.

Genomic Valley Biotech Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 53.94%
• Dec 2025: 53.94%
• Sept 2025: 53.28%
• Jun 2025: 53.28%
• Mar 2025: 53.22%

Public holding remains stable with consistent retail participation.

Genomic Valley Biotech Ltd Government Holding

Government holding in Genomic Valley Biotech Ltd currently stands at 0%.

Genomic Valley Biotech Ltd operates without significant government ownership.

Genomic Valley Biotech Ltd Shareholding Analysis Summary

The Genomic Valley Biotech Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Genomic Valley Biotech Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Genomic Valley Biotech Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.